Copyright
©The Author(s) 2025.
World J Hepatol. Jun 27, 2025; 17(6): 108100
Published online Jun 27, 2025. doi: 10.4254/wjh.v17.i6.108100
Published online Jun 27, 2025. doi: 10.4254/wjh.v17.i6.108100
Table 2 Outcomes between short-course and long-course antimicrobial treatment groups, n (%)
Outcomes | Short-course treatment (< 14 days) | Long-course treatment (≥ 14 days) | P value |
30-day mortality | 0 (0) | 0 (0) | |
Recurrence of cholangitis within 3 months | 1.000 | ||
Yes | 1 (5.3) | 2 (8.0) | |
No | 18 (94.7) | 23 (92.0) | |
Reinfection with the same organism within 3 months | 0 (0) | 0 (0) | |
Length of hospital stay (median, interquartile range) | 12.0 (7.5-13.0) | 14.0 (9.0-18.0) | 0.092 |
- Citation: Kim Y, Ishikawa K, Nakamura K, Ikusaka H, Yokosuka R, Yamazaki T, Suzuki Y, Okuyama S, Takagi K, Fukuda K. Comparison between short-course and long-course antimicrobial treatments for acute cholangitis with gram-positive coccus bacteremia after endoscopic retrograde cholangiopancreatography. World J Hepatol 2025; 17(6): 108100
- URL: https://www.wjgnet.com/1948-5182/full/v17/i6/108100.htm
- DOI: https://dx.doi.org/10.4254/wjh.v17.i6.108100